Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Efficacy and Safety of TenoMiR in Lateral Epicondylitis
NCT06192927 · View on ClinicalTrials.gov ↗
Study Summary
This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of providing a more reliable treatment than those currently available and can be given at the time of first diagnosis, so that recovery can begin as soon as possible. The study drug has been tested in humans in an earlier study, and appeared to be safe and well-tolerated. This study aims to test the study drug in a larger number of participants.
Conditions Studied
Interventions
- DRUG 0.9% Sodium Chloride Injection
- DRUG TenoMiR
Study Locations (9)
Other
- Panthera Biopartners — Enfield
- Panthera Biopartners — Glasgow
- Glasgow Clinical Research Facility — Glasgow
- Panthera Biopartners — Preston
- Panthera Biopartners — Rochdale
- Panthera Biopartners — Sheffield
New York
- Hospital for Special Surgery — New York
- NYU Langone Health — New York
California
- Stanford Medicine — Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-04-10 |
| Est. Completion | 2025-06-12 |
| Phase | Phase 2 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06192927
The ClinicalTrials.gov registry entry for NCT06192927 describes a study currently listed as completed. It is categorized as Phase 2, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Causeway Therapeutics, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Tennis Elbow appearing as the primary indexed condition, and to 2 interventions — of which 0.9% Sodium Chloride Injection is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06192927 reports 9 study locations spanning 3 distinct geographic areas — top geographies include Other, New York, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06192927 about?
NCT06192927 is a clinical study titled "Efficacy and Safety of TenoMiR in Lateral Epicondylitis". This study is testing a drug called TenoMiR that is being developed for the treatment of tennis elbow (lateral epicondylitis). The study drug is a new compound that works by improving the quality of the collagen which helps repair damage to the elbow. The study drug is being developed in the hope of...
What is the current status of trial NCT06192927?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 123 participants. The study started on 2024-04-10. Estimated completion is 2025-06-12.
What conditions does trial NCT06192927 study?
This clinical trial studies the following conditions: Tennis Elbow. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06192927?
The interventions under investigation include: 0.9% Sodium Chloride Injection (DRUG), TenoMiR (DRUG). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06192927?
This trial is sponsored by Causeway Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06192927 being conducted?
This trial has 9 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.